Biophysical inhibition of synthetic lung surfactants.
The biophysical activity and inhibition of a series of synthetic surfactant mixtures was studied and correlated with physiological effectiveness in restoring pressure-volume (P-V) mechanics of excised lungs. Results showed that several simple mixtures of dipalmitoyl phosphatidylcholine (DPPC) with fatty acids or diacylglycerols could be formulated to give good adsorption facility and dynamic surface tension lowering to less than 1 mN/m in pulsating bubble measurements at 37 degrees C. However, although biophysical activity approached that of natural lung surfactant (LS) and a related surfactant extract (CLSE) under normal conditions, surface properties were sharply inhibited by relatively small amounts of the plasma protein albumin (2 mg/ml) with minimum surface tensions greater than 30 nM/m even at high surfactant concentrations (5-20 mg lipids/ml). This sensitivity to biophysical inhibition was markedly increased compared to LS and CLSE, and had direct consequences for physiological efficacy: in spite of initially high activity, synthetic surfactants did not exert beneficial effects on P-V mechanics when instilled into surfactant-deficient excised rat lungs. Endogenous protein material was shown to be present upon surfactant recovery by lavage, and bubble measurements confirmed surface activity well below pre-instillation levels. Moreover, full biophysical activity was restored when lavage fluid was extracted to separate the synthetic surfactants from endogenous inhibitors. These results show that it is important to define relative sensitivity to biophysical inhibition in the development of effective lung surfactant substitutes. In addition, the existence of inhibition effects can generate an apparent lack of correspondence between initial biophysical activity and ultimate physiological actions of exogenous surfactant mixtures.
Holm
B A
BA
Department of Gynecology/Obstetrics, State University of New York, Buffalo 14222.
Venkitaraman
A R
AR
Enhorning
G
G
Notter
R H
RH
D015060:1,2-Dipalmitoylphosphatidylcholine; D000818:Animals; D001798:Blood Proteins / Q000502:physiology; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis*; D002417:Cattle; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004075:Diglycerides; D004347:Drug Interactions; D005230:Fatty Acids, Nonesterified; D005989:Glycerides; D008168:Lung / Q000187:drug effects*; D011663:Pulmonary Surfactants / Q000032:analysis* / Q000138:chemical synthesis / Q000494:pharmacology; D051381:Rats
D001798:Blood Proteins; D004075:Diglycerides; D005230:Fatty Acids, Nonesterified; D005989:Glycerides; D011663:Pulmonary Surfactants; D015060:1,2-Dipalmitoylphosphatidylcholine